GLI1 and lung cancer: In addition to a probable transcriptional biofeedback of the GLI-1 protein, in solid epithelial tumors, overexpression of the lncRNA GLI1-AS and loss of expression of the lncRNA GAS5 are both probably involved in resistance to oncology therapy in lung cancer (Figure 5) [115].